Search

everythinglearnresearchcommunity

for

Search:↓

A new compound shows promise as a topical treatment for hair loss.

Baricitinib effectively promotes beard regrowth in most men with alopecia areata universalis.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

Baricitinib for alopecia areata may rarely cause eye issues like keratitis.

AH-001 could be a safer and more effective treatment for hair loss.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

Oral baricitinib is effective and safe for treating alopecia areata.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

ZD1839 can cause skin issues like acne and hair changes.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Baricitinib is effective and safe for treating severe alopecia areata.

The name Janus is fitting for JAK inhibitors as they revolutionize dermatology treatments.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

Eclipta alba extract may work as an anticancer agent and help reverse drug resistance.